Studies have shown that mutations in the three proteins (REL, IκB, p300) are involved in the NF‐κB activation in human B‐cell lymphoma cell line RC‐K8.287, 288. The gene discussed is NFKB1; the disease is B-cell non-Hodgkin lymphoma.